<DOC>
	<DOCNO>NCT00003282</DOCNO>
	<brief_summary>Diagnostic procedure use drug EF5 detect presence oxygen tumor cell may help plan effective treatment solid tumor . This phase I trial study well EF5 work detect presence oxygen tumor cell patient solid tumor biopsied remove surgery</brief_summary>
	<brief_title>EF5 Treating Patients With Solid Tumors</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Determine optimal dose etanidazole derivative EF5 safely tolerate provide optimal signal-to-noise ratio patient solid tumor . II . Determine toxic effect EF5 patient population . III . Determine pharmacokinetics EF5 patient population . IV . Determine dose EF5 provide mean signal-to-noise ratio ( maximum binding anoxia minimum binding ) 75 . V. Determine relationship tumor oxygenation EF5 bind needle electrode measurement . VI . Compare level EF5 bind region low high blood flow . OUTLINE : This dose-escalation study . Patients receive etanidazole derivative EF5 IV 1-2 hour begin approximately 24 hour prior surgery . Tumors resect biopsied Eppendorf needle electrode measurement . Cohorts 6 patient receive escalate dos EF5 maximum tolerate dose ( MTD ) optimal dose determine . The MTD define dose precede 2 patient experience dose-limiting toxicity . The optimal dose define dose level MTD result signal-to-noise ratio 75 great . Thirty additional patient treat optimal dose . Patients follow 30-45 day post EF5 infusion . PROJECTED ACCRUAL : A total 50 patient accrue study .</detailed_description>
	<criteria>Histologically confirm tumor highly suspicious cancerous mass base image clinical sign indicative direct biopsy/cellular diagnosis precede surgery Must clinical condition physiologic status demonstrate appropriate standard initial therapy tumor surgical biopsy resection Performance status ECOG 02 Life expectancy specify WBC great 2,000/mm^3 Platelet count great 100,000/mm^3 Bilirubin less 2.0 mg/dL Creatinine le 2.0 mg/dL Creatinine clearance great 50 mL/min No significant cardiac disease would preclude safe use general anesthesia No significant pulmonary disease would preclude safe use general anesthesia Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 1 month study No history grade III IV peripheral neuropathy See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>